CDMO News
Scinai Immunotherapeutics Secures Five-Year Contract Manufacturing Deal with Ayana Pharma
Scinai Immunotherapeutics Ltd. announced on April 8, 2024, that it has signed a five-year Master Service Agreement (MSA) with Ayana Pharma Ltd. The agreement involves Scinai’s CDMO business unit, Scinai Bioservices, providing drug development and cGMP manufacturing services to Ayana. This
9 April 2024
Stay ahead of trends and best practices
